Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

15.01
-0.2600-1.70%
Post-market: 15.100.0900+0.60%19:59 EDT
Volume:1.43M
Turnover:21.38M
Market Cap:1.79B
PE:-14.43
High:15.30
Open:15.24
Low:14.70
Close:15.27
Loading ...
Jan 31, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Oct 19, 2023

Major Issues Report

Form 8-K - Current report
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Sep 16, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Sep 16, 2023

Correspondence

Form CORRESP - Correspondence
Sep 15, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]